Non-hormonal steroid modulators of NF-kappa beta for treatment of disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10799514
APP PUB NO 20160375037A1
SERIAL NO

15197118

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds and methods which may be useful as treatments of diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REVERAGEN BIOPHARMA INC155 GIBBS STREET SUITE 433 ROCKVILLE MD 20850

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Damsker, Jesse Washington, US 17 45
Hoffman, Eric Kensington, US 73 1890
McCall, John M Boca Grande, US 93 846
Nagaraju, Kanneboyina Kensington, US 16 131

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 13, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 13, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00